Free Trial
TSE:MBX

Microbix Biosystems (MBX) Stock Price, News & Analysis

Microbix Biosystems logo
C$0.30 -0.01 (-3.23%)
As of 10/2/2026 12:32 PM Eastern

About Microbix Biosystems Stock (TSE:MBX)

Advanced

Key Stats

Today's Range
C$0.29
▼
C$0.30
50-Day Range
C$0.28
▼
C$0.32
52-Week Range
C$0.21
▼
C$0.33
Volume
9,256 shs
Average Volume
46,657 shs
Market Capitalization
C$41.09 million
P/E Ratio
N/A
Dividend Yield
2.30%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Microbix Biosystems Inc. creates proprietary biological products for human health, with over 120 skilled employees and revenues of C$ 18.6 million in its last reported fiscal year (2025). It enables the worldwide commercialization of diagnostic assays by making a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs ¿ ) and reference materials (QUANTDx ¿ ) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its antigens drive the antibody tests of approximately 100 diagnostics makers, while QAPs or QUANTDx are sold to clinical lab accreditation organizations, diagnostics companies, and clinical labs. Microbix QAPs are now available in over 30 countries, supported by a network of international distributors.

Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MBX Stock News Headlines

Stocks in play: Microbix Biosystems Inc.
A new type of AI could unleash gains of up to 10,000%
A new AI category called Accelerated AI is starting to gain traction, and most investors haven't caught on yet. Early movers in past technology shifts have seen outsized results, and this emerging niche is drawing comparisons. Get the name and ticker of the leading Accelerated AI company making waves right now.tc pixel
See More Headlines

MBX Stock Analysis - Frequently Asked Questions

Microbix Biosystems' stock was trading at C$0.23 at the beginning of 2026. Since then, MBX stock has increased by 30.4% and is now trading at C$0.30.

Microbix Biosystems Inc. (TSE:MBX) announced its quarterly earnings data on Thursday, August, 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $4.06 million for the quarter. Microbix Biosystems had a negative trailing twelve-month return on equity of 18.83% and a negative net margin of 31.72%.
Read the conference call transcript
.

Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Microbix Biosystems investors own include TransAlta Renewables (RNW), Moderna (MRNA), Canopy Growth (CGC), Organigram (OGI), VEON (VEON) and

Company Calendar

Last Earnings
8/13/2026
Today
10/04/2026

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
TSE:MBX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
15.00
P/E Growth
N/A
Net Income
C$3.39 million
Net Margins
-31.72%
Pretax Margin
N/A
Return on Equity
-18.83%
Return on Assets
3.82%

Debt

Debt-to-Equity Ratio
27.69
Current Ratio
6.89
Quick Ratio
5.57

Sales & Book Value

Annual Sales
C$15.40 million
Price / Sales
2.67
Cash Flow
C$0.07 per share
Price / Cash Flow
4.13
Book Value
C$0.18 per share
Price / Book
1.66

Miscellaneous

Outstanding Shares
136,969,000
Free Float
N/A
Market Cap
C$41.09 million
Optionable
Not Optionable
Beta
0.61
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (TSE:MBX) was last updated on 10/4/2026 by MarketBeat.com Staff.
From Our Partners